Comparison of Time to Achieve HIV RNA <400 copies/ml and <50 copies/ml in Phase III, Blinded, Randomized Clinical Trial of Kaletra vs. NFV in ARV-Naive Patients

For full access to this item, please log in.

Title: Comparison of Time to Achieve HIV RNA <400 copies/ml and <50 copies/ml in Phase III, Blinded, Randomized Clinical Trial of Kaletra vs. NFV in ARV-Naive Patients
Author: Abbott Laboratories |
Publication: 2001
Rights/Permissions: The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Subject terms: reports
Series/Folder Title: Disease Management > AIDS Treatment > Pharmaceutical Treatment > General
Item type:: reports
Link to this Item: https://quod.lib.umich.edu/c/cohenaids/5571095.0291.034
Cite this Item: "Comparison of Time to Achieve HIV RNA <400 copies/ml and <50 copies/ml in Phase III, Blinded, Randomized Clinical Trial of Kaletra vs. NFV in ARV-Naive Patients." In the digital collection Jon Cohen AIDS Research Collection. https://quod.lib.umich.edu/c/cohenaids/5571095.0291.034. University of Michigan Library Digital Collections. Accessed May 10, 2025.

Contents